3 terminated, 2 completed, 1 unknown. 2 Not applicable, 2 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 2 | Terminated 1, Unknown 1 |
| Phase 1 | 2 | Terminated 2 |
Follow prolyl-proline: new trials by email Literature Review of prolyl-proline trials Research Report on prolyl-proline
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Novel Digital Patient-Reported Outcomes Tool for Diabetes Management Mobile Health (mHealth) Patient-Reported Outcome (PRO) tool - Type 2 Diabetes | Not applicable | Terminated | NYU Langone Health | 37 | 2025-11-04 | 2026-08-27 |
| Long-Term Effectiveness of the Motiva Implants® Round and Round Ergonomix MRI and PRO - Breast Augmentation | Completed | Motiva USA LLC | 111 | 2022-11-22 | 2024-10-31 | |
| Clinical and Functional Outcomes 2 Years After ACL Repair and InternalBrace Ligament Augmentation in Comparison With ACL Reconstruction collection of Patient Reported Outcome (PRO) data, collection of anthropometric and clinical functional data, gait analysis - Injury of the Anterior Cruciate Ligament (ACL) | Completed | University Hospital, Basel, Switzerland | 68 | 2020-04-23 | 2023-01-19 | |
| Patient-Reported Outcomes Integrated in the Follow-up of Patients With Hematological Cancer Completion of patient-reported outcome (PRO) questionnaires - Hematological Cancer | Not applicable | Unknown | Zealand University Hospital | 225 | 2016-09-01 | 2017-02-17 |
| Single Dose Trial Comparing the Plasma Levels of Two Different Analgesic Transdermal Patch Formulations Transtec (R) PRO (buprenorphine) - Healthy | Phase 1 | Terminated | Grünenthal GmbH | 24 | 2006-10-01 | 2007-07-06 |
| Multiple Dose Trial Comparing the Plasma Levels of Two Different Analgesic Transdermal Patch Formulations Patch with centrally acting analgesic, Transtec(R) PRO (buprenorphine) - Healthy | Phase 1 | Terminated | Grünenthal GmbH | 24 | 2006-10-01 | 2016-01-11 |
Grünenthal GmbH (2) · Motiva USA LLC (1) · NYU Langone Health (1) · University Hospital, Basel, Switzerland (1) · Zealand University Hospital (1)
Germany (2) · Costa Rica (1) · Denmark (1) · Switzerland (1) · United States (1)
Devin Mann (1) · Hans Hasselbalch, professor (1) · Sebastian Mueller, Dr. med. (1)
PMID 32217877, PMID 35105587, PMID 37675973, PMID 37735271, PMID 37794432